The impact of missing deaths on survival analyses conducted in an oncology EHR database Published August 2018 Citation Carrigan, G, Whipple, S, Taylor, M.D., Torres, A.Z., Gossai, A, Arnieri, B, Tucker, M, Hofmeister, P.P., Lambert, P, Griffith, S.D., Capra, W.B. . International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE). . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/ICPE-2018-missing-deaths-poster-v3.pdf Authors: Sources:International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) Share Posted inPublicationsMethodology More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerESMO Real-World Data and Digital OncologyFebruary 2025Characterisation of oncology EHR-derived real-world data in the UK, Germany, and JapanAdamson B, Horne E, Xu C, et al.Real-world evidencePublication summaryPublicationsData scienceMethodologyHTA and market accessFrontiers in Drug Safety and RegulationAugust 2024Measurement error and bias in real-world oncology endpoints when constructing external control armsAckerman B, Gan R, Meyer C, et al. Publication summaryPublicationsMethodologyMultiple myeloma